{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:30:28Z","timestamp":1777465828857,"version":"3.51.4"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T00:00:00Z","timestamp":1150761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T00:00:00Z","timestamp":1150761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1038\/sj.mp.4001854","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T11:18:47Z","timestamp":1150802327000},"page":"721-736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":294,"title":["Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease"],"prefix":"10.1038","volume":"11","author":[{"given":"I J","family":"Martins","sequence":"first","affiliation":[]},{"given":"E","family":"Hone","sequence":"additional","affiliation":[]},{"given":"J K","family":"Foster","sequence":"additional","affiliation":[]},{"given":"S I","family":"S\u00fcnram-Lea","sequence":"additional","affiliation":[]},{"given":"A","family":"Gnjec","sequence":"additional","affiliation":[]},{"given":"S J","family":"Fuller","sequence":"additional","affiliation":[]},{"given":"D","family":"Nolan","sequence":"additional","affiliation":[]},{"given":"S E","family":"Gandy","sequence":"additional","affiliation":[]},{"given":"R N","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,6,20]]},"reference":[{"key":"BF4001854_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0749-3797(98)00139-1","volume":"16","author":"SG Post","year":"1999","unstructured":"Post SG . Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective. Am J Prev Med 1999; 16: 105\u2013110.","journal-title":"Am J Prev Med"},{"key":"BF4001854_CR2","unstructured":"Aged and Community Care Division. Department of Health & Family Services: Canberra, 1998 p. 81."},{"key":"BF4001854_CR3","first-page":"1","volume":"51","author":"E Arias","year":"2003","unstructured":"Arias E, Smith BL . Deaths: preliminary data for 2001. Natl Vital Stat Rep 2003; 51: 1\u201344.","journal-title":"Natl Vital Stat Rep"},{"key":"BF4001854_CR4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","volume":"262","author":"DA Evans","year":"1989","unstructured":"Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989; 262: 2551\u20132556.","journal-title":"JAMA"},{"key":"BF4001854_CR5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease. Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"key":"BF4001854_CR6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","volume":"46","author":"MS Mega","year":"1996","unstructured":"Mega MS, Cummings JL, Fiorello T, Gornbein J . The spectrum of behavioural changes in Alzheimer's disease. Neurology 1996; 46: 130\u2013135.","journal-title":"Neurology"},{"key":"BF4001854_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1353\/pbm.1997.0020","volume":"40","author":"S Gilman","year":"1997","unstructured":"Gilman S . Alzheimer's disease. Perspect Biol Med 1997; 40: 230\u2013245.","journal-title":"Perspect Biol Med"},{"key":"BF4001854_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0301-0082(97)00014-2","volume":"52","author":"DC Rubinsztein","year":"1997","unstructured":"Rubinsztein DC . The genetics of Alzheimer's disease. Prog Neurobiol 1997; 52: 447\u2013454.","journal-title":"Prog Neurobiol"},{"key":"BF4001854_CR9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992; 360: 672\u2013674.","journal-title":"Nature"},{"key":"BF4001854_CR10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1292-335","volume":"2","author":"C Van Broeckhoven","year":"1992","unstructured":"Van Broeckhoven C, Backhovens H, Cruts M, De Winter G, Bruyland M, Cras P et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992; 2: 335\u2013339.","journal-title":"Nat Genet"},{"key":"BF4001854_CR11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","volume":"5","author":"R Sherrington","year":"1996","unstructured":"Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA et al. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet 1996; 5: 985\u2013988.","journal-title":"Hum Mol Genet"},{"key":"BF4001854_CR12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754\u2013760.","journal-title":"Nature"},{"key":"BF4001854_CR13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00001756-199704140-00043","volume":"8","author":"JB Kwok","year":"1997","unstructured":"Kwok JB, Taddei K, Hallupp M, Fisher C, Brooks WS, Broe GA et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport 1997; 8: 1537\u20131542.","journal-title":"NeuroReport"},{"key":"BF4001854_CR14","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1097\/00001756-199810050-00034","volume":"9","author":"K Taddei","year":"1998","unstructured":"Taddei K, Kwok JB, Kril JJ, Halliday GM, Creasey H, Hallupp M et al. Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. NeuroReport 1998; 9: 3335\u20133339.","journal-title":"NeuroReport"},{"key":"BF4001854_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.1997.03540340059034","volume":"277","author":"CL Lendon","year":"1997","unstructured":"Lendon CL, Ashall F, Goate AM . Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 1997; 277: 825\u2013831.","journal-title":"JAMA"},{"key":"BF4001854_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410190502","volume":"19","author":"WA Rocca","year":"1986","unstructured":"Rocca WA, Amaducci LA, Schoenberg BS . Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986; 19: 415\u2013424.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0197-4580(90)90024-T","volume":"11","author":"DL Sparks","year":"1990","unstructured":"Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR . Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990; 11: 601\u2013607.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.802225","volume":"27","author":"MF Elias","year":"2003","unstructured":"Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB . Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 2003; 27: 260\u2013268.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF4001854_CR19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","volume":"163","author":"D Gustafson","year":"2003","unstructured":"Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524\u20131528.","journal-title":"Arch Intern Med"},{"key":"BF4001854_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/aje\/154.7.635","volume":"154","author":"JA Luchsinger","year":"2001","unstructured":"Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R . Diabetes mellitus and the risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001; 154: 635\u2013641.","journal-title":"Am J Epidemiol"},{"key":"BF4001854_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","volume":"16","author":"R Stewart","year":"1999","unstructured":"Stewart R, Liolitsa D . Type 2 diabetes, cognitive impairment and dementia. Diabet Med 1999; 16: 93\u2013112.","journal-title":"Diabet Med"},{"key":"BF4001854_CR22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1096-8628(20010108)105:1<76::AID-AJMG1066>3.0.CO;2-R","volume":"105","author":"L Sanchez","year":"2001","unstructured":"Sanchez L, Alvarez V, Gonzalez P, Gonzalez I, Alvarez R, Coto E . Variation in the LRP-associated protein gene (LRPAP1) is associated with late onset Alzheimer disease. Am J Med Genet 2001; 105: 76\u201378.","journal-title":"Am J Med Genet"},{"key":"BF4001854_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(98)00141-4","volume":"244","author":"MI Kamboh","year":"1998","unstructured":"Kamboh MI, Ferrell RE, Dekosky ST . Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor related protein gene. Neurosci Lett 1998; 244: 65\u201368.","journal-title":"Neurosci Lett"},{"key":"BF4001854_CR24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1399-0004.2000.580410.x","volume":"58","author":"Y Hatanaka","year":"2000","unstructured":"Hatanaka Y, Kamino K, Fukuo K, Mitsuda N, Nishiwaki-Ueda Y, Sato N et al. Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clin Genet 2000; 58: 319\u2013323.","journal-title":"Clin Genet"},{"key":"BF4001854_CR25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.55.8.1158","volume":"55","author":"BL Plassman","year":"2000","unstructured":"Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 2000; 55: 1158\u20131166.","journal-title":"Neurology"},{"key":"BF4001854_CR26","first-page":"511","volume":"75","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA . Traumatic brain injury as a risk factor for Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 511\u2013512.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF4001854_CR27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archneur.1993.00540070069018","volume":"50","author":"JG Buckwalter","year":"1993","unstructured":"Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW . Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol 1993; 50: 757\u2013760.","journal-title":"Arch Neurol"},{"key":"BF4001854_CR28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.410270412","volume":"27","author":"MY Zhang","year":"1990","unstructured":"Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428\u2013437.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR29","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K . Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985; 82: 4245\u20134249.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Comm 1984; 120: 885\u2013890.","journal-title":"Biochem Biophys Res Comm"},{"key":"BF4001854_CR31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733\u2013736.","journal-title":"Nature"},{"key":"BF4001854_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1439760","volume":"258","author":"M Shoji","year":"1992","unstructured":"Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 1992; 258: 126\u2013129.","journal-title":"Science"},{"key":"BF4001854_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/357500a0","volume":"357","author":"C Haass","year":"1992","unstructured":"Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ . Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992; 357: 500\u2013503.","journal-title":"Nature"},{"key":"BF4001854_CR34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286: 735\u2013741.","journal-title":"Science"},{"key":"BF4001854_CR35","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1037392100","volume":"100","author":"WT Kimberley","year":"2003","unstructured":"Kimberley WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ . Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 2003; 100: 6382\u20136387.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR36","doi-asserted-by":"crossref","first-page":"32295","DOI":"10.1074\/jbc.274.45.32295","volume":"274","author":"S Soriano","year":"1999","unstructured":"Soriano S, Chyung AS, Chen X, Stokin GB, Lee VM, Koo EH . Expression of beta amyloid precursor protein-CD3 gamma chimeras to demonstrate the selective generation of amyloid beta (1\u201340) and amyloid beta (1\u201342) peptides within secretory and endocytic compartments. J Biol Chem 1999; 274: 32295\u201332300.","journal-title":"J Biol Chem"},{"issue":"6","key":"BF4001854_CR37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999; 46 (6): 860\u2013866.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00005072-199908000-00003","volume":"58","author":"J Miklossy","year":"1999","unstructured":"Miklossy J, Taddei K, Martins R, Escher G, Kraftsik R, Pillevuit O et al. Alzheimer disease: curly fibers and tangles in organs other than brain. J Neuropathol Exp Neurol 1999; 58: 803\u2013814.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF4001854_CR39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L","volume":"50","author":"DL Sparks","year":"2000","unstructured":"Sparks DL, Martin TA, Gross DR, Hunsaker JC . Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech 2000; 50: 287\u2013290.","journal-title":"Microsc Res Tech"},{"key":"BF4001854_CR40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/01.WNL.0000150886.50187.30","volume":"64","author":"LS Honig","year":"2005","unstructured":"Honig LS, Kukull W, Mayeux R . Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005; 64: 494\u2013500.","journal-title":"Neurology"},{"key":"BF4001854_CR41","first-page":"42","volume":"2","author":"WB Grant","year":"1997","unstructured":"Grant WB . Dietary links to Alzheimer's disease. Alz Dis Rev 1997; 2: 42\u201355.","journal-title":"Alz Dis Rev"},{"key":"BF4001854_CR42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/13506129909007315","volume":"6","author":"AE Roher","year":"1999","unstructured":"Roher AE, Kuo YM, Kokjohn KM, Emmerling MR, Gracon S . Amyloid and lipids in the pathology of Alzheimer's disease. Amyloid 1999; 6: 136\u2013145.","journal-title":"Amyloid"},{"key":"BF4001854_CR43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","volume":"252","author":"YM Kuo","year":"1998","unstructured":"Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D et al. Elevated low density lipoprotein in Alzheimer's disease correlates with brain abeta1\u201342 levels. Biochem Biophys Res Comm 1998; 252: 711\u2013715.","journal-title":"Biochem Biophys Res Comm"},{"key":"BF4001854_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","volume":"21","author":"A Merched","year":"2000","unstructured":"Merched A, Xia Y, Visvikis S, Serot JM, Siest G . Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 2000; 21: 27\u201330.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11883-005-0029-x","volume":"7","author":"D Kazi","year":"2005","unstructured":"Kazi D, Farmer JA . Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary. Curr Atheroscler Rep 2005; 7: 88\u201394.","journal-title":"Curr Atheroscler Rep"},{"key":"BF4001854_CR46","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","volume":"24","author":"H Hayashi","year":"2004","unstructured":"Hayashi H, Kimura N, Yamaguchi H, Hasegawa K, Yokoseki T, Shibata M et al. A seed for Alzheimer amyloid in the brain. J Neurosci 2004; 24: 4894\u20134902.","journal-title":"J Neurosci"},{"key":"BF4001854_CR47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","volume":"100","author":"MP Burns","year":"2003","unstructured":"Burns MP, Noble WJ, Olm V, Gaynor K, Casey E, LaFrancois J et al. Co-localization of cholesterol, apolipoprotein E and fibrillar abeta in amyloid plaques. Brain Res Mol Brain Res 2003; 100: 119\u2013125.","journal-title":"Brain Res Mol Brain Res"},{"key":"BF4001854_CR48","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/bi0501030","volume":"44","author":"J Bieschke","year":"2005","unstructured":"Bieschke J, Zhang Q, Powers ET, Lerner RA, Kelly JW . Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 2005; 44: 4977\u20134983.","journal-title":"Biochemistry"},{"key":"BF4001854_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1527-3458.2004.tb00009.x","volume":"10","author":"B Wolozin","year":"2004","unstructured":"Wolozin B, Brown J, Theisler C, Silberman S . The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev 2004; 10: 127\u2013146.","journal-title":"CNS Drug Rev"},{"key":"BF4001854_CR50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3956(01)00050-4","volume":"36","author":"A Papassotiropoulos","year":"2002","unstructured":"Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002; 36: 27\u201332.","journal-title":"J Psychiatr Res"},{"key":"BF4001854_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3940(02)00164-7","volume":"32","author":"P Schonknecht","year":"2002","unstructured":"Schonknecht P, Lutjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett 2002; 32: 83\u201385.","journal-title":"Neurosci Lett"},{"key":"BF4001854_CR52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","volume":"41","author":"D Lutjohann","year":"2000","unstructured":"Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD . Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000; 41: 195\u2013198.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR53","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","volume":"11","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli M, Jessen F, Rao ML et al. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. NeuroReport 2000; 11: 1959\u20131962.","journal-title":"NeuroReport"},{"key":"BF4001854_CR54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001756-200401190-00019","volume":"15","author":"KA Chalmers","year":"2004","unstructured":"Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S . Apo E promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. NeuroReport 2004; 15: 95\u201398.","journal-title":"NeuroReport"},{"key":"BF4001854_CR55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-004-1107-9","volume":"114","author":"A Johansson","year":"2004","unstructured":"Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N et al. Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet 2004; 114: 581\u2013587.","journal-title":"Hum Genet"},{"key":"BF4001854_CR56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(02)00443-3","volume":"328","author":"P Desai","year":"2002","unstructured":"Desai P, DeKosky ST, Kamboh MI . Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett 2002; 328: 9\u201312.","journal-title":"Neurosci Lett"},{"key":"BF4001854_CR57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","volume":"41","author":"D Lutjohann","year":"2000","unstructured":"Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000; 41: 195\u2013198.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M, Hamon Y, Chimini G . The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001; 42: 1007\u20131017.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR59","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354\u20131357.","journal-title":"Science"},{"key":"BF4001854_CR60","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","volume":"278","author":"RP Koldamova","year":"2003","unstructured":"Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA et al. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid \u03b2 secretion. J Biol Chem 2003; 278: 13244\u201313256.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR61","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 2004; 279: 40987\u201340993.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0197-4580(02)00094-5","volume":"24","author":"MA Wollmer","year":"2003","unstructured":"Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T et al. ABCA 1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 2003; 24: 421\u2013426.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR63","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1073\/pnas.2335135100","volume":"100","author":"A Sundqvist","year":"2003","unstructured":"Sundqvist A, Ericsson J . Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. Proc Natl Acad Sci USA 2003; 100: 13833\u201313838.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","volume":"40","author":"H Shimano","year":"2001","unstructured":"Shimano H . Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001; 40: 439\u2013452.","journal-title":"Prog Lipid Res"},{"key":"BF4001854_CR65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000080023","volume":"18","author":"C Spell","year":"2004","unstructured":"Spell C, Kolsch H, Lutjohann D, Kerksiek A, Hentschel F, Damian M et al. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the apoE4 allele. Dement Geriatr Cogn Disord 2004; 18: 245\u2013249.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BF4001854_CR66","first-page":"31","volume":"7","author":"BM Austen","year":"2003","unstructured":"Austen BM, Sidera C, Liu C, Frears E . The role of intracellular cholesterol on the processing of the \u03b2-amyloid precursor protein. J Nutr Health Aging 2003; 7: 31\u201336.","journal-title":"J Nutr Health Aging"},{"key":"BF4001854_CR67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R Ehehalt","year":"2003","unstructured":"Ehehalt R, Keller P, Haass C, Thiele C, Simons K . Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003; 160: 113\u2013123.","journal-title":"J Cell Biol"},{"key":"BF4001854_CR68","doi-asserted-by":"crossref","first-page":"44945","DOI":"10.1074\/jbc.M407986200","volume":"279","author":"KS Vetrivel","year":"2004","unstructured":"Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N et al. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 2004; 279: 44945\u201344954.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR69","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","volume":"271","author":"S Bodovitz","year":"1996","unstructured":"Bodovitz S, Klein WL . Cholesterol modulates alpha secretase cleavage of amyloid precursor protein. J Biol Chem 1996; 271: 4436\u20134440.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR70","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K . Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460\u20136464.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR71","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F . Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10. Proc Natl Acad Sci USA 2001; 98: 5815\u20135820.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","volume":"9","author":"S Wahrle","year":"2002","unstructured":"Wahrle S, Das P, Nyborg AC, Mclendon C, Shoji M, Kawarabayashi T et al. Cholesterol dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 2002; 9: 11\u201323.","journal-title":"Neurobiol Dis"},{"key":"BF4001854_CR73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1042\/bj3220893","volume":"322","author":"M Racchi","year":"1997","unstructured":"Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Paoletti R et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 1997; 322: 893\u2013898.","journal-title":"Biochem J"},{"key":"BF4001854_CR74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3480307","volume":"348","author":"JL Galbete","year":"2000","unstructured":"Galbete JL, Martin TR, Peressini E, Modena P, Bianchi R, Forloni G . Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. Biochem J 2000; 348: 307\u2013313.","journal-title":"Biochem J"},{"key":"BF4001854_CR75","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1083\/jcb.200404149","volume":"167","author":"J Abad-Rodriguez","year":"2004","unstructured":"Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 2004; 167: 953\u2013960.","journal-title":"J Cell Biol"},{"key":"BF4001854_CR76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0092-8674(95)90320-8","volume":"82","author":"MZ Kounnas","year":"1995","unstructured":"Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE et al. LDL receptor related protein, a multifunctional ApoE receptor binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995; 82: 331\u2013340.","journal-title":"Cell"},{"key":"BF4001854_CR77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1515\/REVNEURO.2005.16.2.123","volume":"16","author":"CV Zerbinatti","year":"2005","unstructured":"Zerbinatti CV, Bu G . LRP and Alzheimer's disease. Rev Neurosci 2005; 16: 123\u2013135.","journal-title":"Rev Neurosci"},{"key":"BF4001854_CR78","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.M414248200","volume":"280","author":"CA von Arnim","year":"2005","unstructured":"von Arnim CA, Kinoshita A, Peltan ID, Tangredi MM, Herl L, Lee BM et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem 2005; 280: 17777\u201317785.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR79","doi-asserted-by":"crossref","first-page":"27303","DOI":"10.1074\/jbc.M413969200","volume":"280","author":"A Lleo","year":"2005","unstructured":"Lleo A, Waldron E, von Arnim CA, Herl L, Tangredi MM, Peltan ID et al. Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. J Biol Chem 2005; 280: 27303\u201327309.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR80","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MOW Grimm","year":"2005","unstructured":"Grimm MOW, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-\u03b2 and presenilin. Nat Cell Biol 2005; 7: 1118\u20131123.","journal-title":"Nat Cell Biol"},{"key":"BF4001854_CR81","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 2070\u20132075.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR82","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.172510899","volume":"99","author":"L Wang","year":"2002","unstructured":"Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson J-A . Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci USA 2002; 99: 13878\u201313883.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR83","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.1074\/jbc.M300760200","volume":"278","author":"Y Sun","year":"2003","unstructured":"Sun Y, Yao J, Kim TW, Tall AR . Expression of liver X receptor target genes decreases cellular amyloid \u03b2 peptide secretion. J Biol Chem 2003; 278: 27688\u201327694.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR84","first-page":"1095","volume":"4","author":"A Miyazaki","year":"2003","unstructured":"Miyazaki A, Sakai M, Sakamoto Y, Horiuchi S . Acyl-coenzyme A: cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis. Curr Opin Investig Drugs 2003; 4: 1095\u20131099.","journal-title":"Curr Opin Investig Drugs"},{"key":"BF4001854_CR85","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ncb1001-905","volume":"3","author":"L Puglielli","year":"2001","unstructured":"Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT et al. Acyl-coenzyme A:cholesterol acyltransferase modulates the generation of the amyloid \u03b2 peptide. Nat Cell Biol 2001; 3: 905\u2013912.","journal-title":"Nat Cell Biol"},{"key":"BF4001854_CR86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/JMN:24:1:093","volume":"24","author":"L Puglielli","year":"2004","unstructured":"Puglielli L, Ellis BC, Ingano LA, Kovacs DM . Role of acyl-coenzyme A:cholesterol acyltransferase activity in the processing of the amyloid precursor protein. J Mol Neurosci 2004; 24: 93\u201396.","journal-title":"J Mol Neurosci"},{"key":"BF4001854_CR87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","volume":"44","author":"B Hutter-Paier","year":"2004","unstructured":"Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A et al. The ACAT inhibitor CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 2004; 44: 227\u2013238.","journal-title":"Neuron"},{"key":"BF4001854_CR88","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.mp.4001296","volume":"8","author":"MA Wollmer","year":"2003","unstructured":"Wollmer MA, Streffer JR, Tsolaki M, Grimaldi LM, Lutjohann D, Thal D et al. Genetic association of acyl-conenzyme A:cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and the risk for Alzheimer's disease. Mol Psychiatry 2003; 8: 635\u2013638.","journal-title":"Mol Psychiatry"},{"key":"BF4001854_CR89","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA . Statins and the risk of dementia. Lancet 2000; 356: 1627\u20131631.","journal-title":"Lancet"},{"key":"BF4001854_CR90","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Rousseau P, Celesia GG, Siegel G . Decreased prevalence of Alzheimer's disease associated with 3-hydroxy3methylglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439\u20131443.","journal-title":"Arch Neurol"},{"key":"BF4001854_CR91","first-page":"377","volume":"6","author":"B Austen","year":"2002","unstructured":"Austen B, Christodoulou G, Terry JE . Relation between cholesterol levels, statins and Alzheimer's disease in the human population. J Nutr Health Aging 2002; 6: 377\u2013382.","journal-title":"J Nutr Health Aging"},{"key":"BF4001854_CR92","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0024-3205(99)00199-X","volume":"65","author":"MH Moghadasian","year":"1999","unstructured":"Moghadasian MH . Clinical pharmacology of 3-hydroxy-3methylglutaryl coenyzme A reductase inhibitors. Life Sci 1999; 65: 1329\u20131337.","journal-title":"Life Sci"},{"key":"BF4001854_CR93","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0197-4580(02)00155-0","volume":"24","author":"I-H Park","year":"2003","unstructured":"Park I-H, Hwang EM, Hong HS, Boo JH, Oh SS, Lee J et al. Lovastatin enhances A\u03b2 production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging 2003; 24: 637\u2013643.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12031-002-0026-2","volume":"19","author":"SS Petanceska","year":"2002","unstructured":"Petanceska SS, DeRosa S, Olm V, Diaz N, Sharma A, Thomas-Bryant T et al. Statin therapy for Alzheimer's disease: will it work? J Mol Neurosci 2002; 19: 155\u2013161.","journal-title":"J Mol Neurosci"},{"key":"BF4001854_CR95","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P et al. Simvastatin strongly reduces levels of Alzheimer's disease \u03b2-amyloid peptides A\u03b242 and A\u03b240 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 5856\u20135861.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000084550","volume":"19","author":"K Hoglund","year":"2005","unstructured":"Hoglund K, Thelen KM, Syversen S, Sjogren M, von Bergmann K, Wallin A et al. The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2005; 19: 256\u2013265.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BF4001854_CR97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bss0720129","volume":"72","author":"MD Ledesma","year":"2005","unstructured":"Ledesma MD, Dotti CG . The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. Biochem Soc Symp 2005; 72: 129\u2013138.","journal-title":"Biochem Soc Symp"},{"key":"BF4001854_CR98","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","volume":"57","author":"A Ruitenberg","year":"2005","unstructured":"Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005; 57: 789\u2013794.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR99","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","volume":"26","author":"J Poirier","year":"2005","unstructured":"Poirier J . Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 2005; 26: 355\u2013361.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D","volume":"88","author":"L Baum","year":"1999","unstructured":"Baum L, Chen L, Masliah E, Chan YS, Ng HK, Pang CP . Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet 1999; 88: 136\u2013139.","journal-title":"Am J Med Genet"},{"key":"BF4001854_CR101","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.bjp.0702668","volume":"127","author":"JC Verd","year":"1999","unstructured":"Verd JC, Peris C, Alegret M, Diaz C, Hernandez G, Vasquez M et al. Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat\/cholesterol fed rabbits. Br J Pharmacol 1999; 127: 1479\u20131485.","journal-title":"Br J Pharmacol"},{"key":"BF4001854_CR102","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-5793(99)00632-8","volume":"452","author":"K Schoonjans","year":"1999","unstructured":"Schoonjans K, Peinado-Onsurbe J, Fruchart JC, Tailleux A, Fievet C, Auwerx J . 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglycerides levels through modulation of apolipoprotein C-III and lipoprotein lipase. FEBS Lett 1999; 452: 160\u2013164.","journal-title":"FEBS Lett"},{"key":"BF4001854_CR103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.285.6.739","volume":"285","author":"HC Hendrie","year":"2001","unstructured":"Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001; 285: 739\u2013747.","journal-title":"JAMA"},{"key":"BF4001854_CR104","doi-asserted-by":"crossref","first-page":"s154","DOI":"10.1093\/geronb\/54B.3.S154","volume":"54","author":"AB Graves","year":"1999","unstructured":"Graves AB, Rajaram L, Bowen JD, McCormick WC, McCurry SM, Larson EB . Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County, WA: the Kane Project. J Gerontol B Psychol Sci Soc Sci 1999; 54: s154\u2013s161.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"BF4001854_CR105","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/01.WNL.0000038345.77753.46","volume":"59","author":"MJ Engelhart","year":"2002","unstructured":"Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC et al. Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 2002; 59: 1915\u20131921.","journal-title":"Neurology"},{"key":"BF4001854_CR106","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-002-0809-1","volume":"110","author":"CW Wu","year":"2003","unstructured":"Wu CW, Liao PC, Lin C, Kuo CJ, Chen ST, Chen HI et al. Brain region dependent increases in \u03b2-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits. J Neural Transm 2003; 110: 641\u2013649.","journal-title":"J Neural Transm"},{"key":"BF4001854_CR107","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1749-6632.2002.tb04838.x","volume":"977","author":"DL Sparks","year":"2002","unstructured":"Sparks DL, Martins RN, Martin T . Rationale for the AD cholesterol lowering treatment trial and sex related differences in \u03b2-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits. Ann NY Acad Sci 2002; 977: 356\u2013366.","journal-title":"Ann NY Acad Sci"},{"key":"BF4001854_CR108","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","volume":"7","author":"LM Refolo","year":"2000","unstructured":"Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7: 321\u2013331.","journal-title":"Neurobiol Dis"},{"key":"BF4001854_CR109","first-page":"659","volume":"19","author":"J Wang","year":"2005","unstructured":"Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 2005; 19: 659\u2013661.","journal-title":"FASEB J"},{"key":"BF4001854_CR110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.steroids.2004.03.012","volume":"69","author":"D Lutjohann","year":"2004","unstructured":"Lutjohann D, Stroick M, Bertsch T, Kuhl S, Lindenthal B, Thelen K et al. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. Steroids 2004; 69: 431\u2013438.","journal-title":"Steroids"},{"key":"BF4001854_CR111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0163-1047(90)90831-P","volume":"53","author":"C Greenwood","year":"1990","unstructured":"Greenwood C, Winocur G . Learning and memory impairment in rats fed a high saturated fat diet. Behav Neural Biol 1990; 53: 74\u201387.","journal-title":"Behav Neural Biol"},{"key":"BF4001854_CR112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1037\/0735-7044.110.3.451","volume":"110","author":"C Greenwood","year":"1996","unstructured":"Greenwood C, Winocur G . Cognitive performance in rats fed high-fat diets: a specific effect of saturated fatty acid intake. Behav Neurosci 1996; 110: 451\u2013459.","journal-title":"Behav Neurosci"},{"key":"BF4001854_CR113","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3758\/BF03327147","volume":"22","author":"G Winocur","year":"1993","unstructured":"Winocur G, Greenwood C . High fat diets impair conditional discrimination learning in rats. Psychobiology 1993; 22: 286\u2013292.","journal-title":"Psychobiology"},{"key":"BF4001854_CR114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-4328(98)00147-8","volume":"101","author":"G Winocur","year":"1999","unstructured":"Winocur G, Greenwood C . The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999; 101: 153\u2013161.","journal-title":"Behav Brain Res"},{"key":"BF4001854_CR115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.802225","volume":"27","author":"MF Elias","year":"2003","unstructured":"Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB . Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 2003; 27: 260\u2013268.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF4001854_CR116","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","volume":"163","author":"D Gustafson","year":"2003","unstructured":"Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18 year follow up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524\u20131528.","journal-title":"Arch Intern Med"},{"key":"BF4001854_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.publhealth.25.101802.122951","volume":"25","author":"MN Haan","year":"2004","unstructured":"Haan MN, Wallace R . Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004; 25: 1\u201324.","journal-title":"Annu Rev Public Health"},{"key":"BF4001854_CR118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-2005-8305","volume":"8","author":"K Balakrishnan","year":"2005","unstructured":"Balakrishnan K, Verdile G, Mehta PD, Beilby J, Nolan D, Galvao DA et al. Plasma A\u03b242 correlates positively with increased body fat in healthy individuals. J Alzheimer's Dis 2005; 8: 269\u2013282.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR119","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556\u20131560.","journal-title":"Arch Neurol"},{"key":"BF4001854_CR120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.1993.tb35701.x","volume":"683","author":"MT Clandinin","year":"1993","unstructured":"Clandinin MT, Cheema S, Field CJ, Baracos VE . Dietary lipids influence insulin action. Ann NY Acad Sci 1993; 683: 151\u2013163.","journal-title":"Ann NY Acad Sci"},{"key":"BF4001854_CR121","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.1997.tb51842.x","volume":"827","author":"LH Storlien","year":"1997","unstructured":"Storlien LH, Kriketos AD, Jenkins AB, Baur LA, Pan DA, Tapsell LC et al. Does dietary fat influence insulin action? Ann NY Acad Sci 1997; 827: 287\u2013301.","journal-title":"Ann NY Acad Sci"},{"key":"BF4001854_CR122","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1096\/fasebj.5.8.2022312","volume":"5","author":"CD Berdanier","year":"1991","unstructured":"Berdanier CD . The BHE rat: an animal model for the study of non-insulin-dependent diabetes mellitus. FASEB J 1991; 5: 2139\u20132144.","journal-title":"FASEB J"},{"key":"BF4001854_CR123","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1462-8902.2004.00356.x","volume":"6","author":"M Manco","year":"2004","unstructured":"Manco M, Calvani C, Mingrone G . Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes metab 2004; 6: 402\u2013413.","journal-title":"Diabetes Obes metab"},{"key":"BF4001854_CR124","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/en.2003-0479","volume":"144","author":"MJ Holness","year":"2003","unstructured":"Holness MJ, Greenwood GK, Smith ND, Sugden MC . Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 2003; 144: 3958\u20133968.","journal-title":"Endocrinology"},{"key":"BF4001854_CR125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s001250050697","volume":"40","author":"JA Marshall","year":"1997","unstructured":"Marshall JA, Bessesen DH, Hamman RF . High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Louis Valley Diabetes Study. Diabetologia 1997; 40: 430\u2013438.","journal-title":"Diabetologia"},{"key":"BF4001854_CR126","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","volume":"39","author":"A Ott","year":"1996","unstructured":"Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM . Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39: 1392\u20131397.","journal-title":"Diabetologia"},{"key":"BF4001854_CR127","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC . Increased risk of type 2 diabetes in Alzheimer's disease. Diabetes 2004; 53: 474\u2013481.","journal-title":"Diabetes"},{"key":"BF4001854_CR128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-8227(03)00084-6","volume":"61","author":"DG Bruce","year":"2003","unstructured":"Bruce DG, Casey GP, Grange V, Clarnette RC, Almeida OP, Foster JK et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle cognition in diabetes study. Diabetes Res Clin Pract 2003; 61: 59\u201367.","journal-title":"Diabetes Res Clin Pract"},{"key":"BF4001854_CR129","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bmj.315.7115.1045","volume":"315","author":"J Kuusisto","year":"1997","unstructured":"Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br Med J 1997; 315: 1045\u20131049.","journal-title":"Br Med J"},{"key":"BF4001854_CR130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","volume":"16","author":"R Stewart","year":"1999","unstructured":"Stewart R, Liolitsa D . Type 2 diabetes, cognitive impairment and dementia. Diabet Med 1999; 16: 93\u2013112.","journal-title":"Diabet Med"},{"key":"BF4001854_CR131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000064928","volume":"14","author":"C MacKnight","year":"2002","unstructured":"MacKnight C, Rockwood K, Awalt E, McDowell I . Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002; 14: 77\u201383.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BF4001854_CR132","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S104161020200844X","volume":"14","author":"LB Hassing","year":"2002","unstructured":"Hassing LB, Johansson B, Nilsson SE, Berg S, Pedersen NL, Gatz M et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population based study of the oldest old. Int Psychogeriatr 2002; 14: 239\u2013248.","journal-title":"Int Psychogeriatr"},{"key":"BF4001854_CR133","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jnutbio.2003.10.006","volume":"15","author":"IJ Martins","year":"2004","unstructured":"Martins IJ, Redgrave TG . Obesity and postprandial lipid metabolism. Feast or famine? J Nutr Biochem 2004; 15: 130\u2013141.","journal-title":"J Nutr Biochem"},{"key":"BF4001854_CR134","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1194\/jlr.M300368-JLR200","volume":"45","author":"J Pihlajamaki","year":"2004","unstructured":"Pihlajamaki J, Gylling H, Miettinen TA, Laakso M . Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004; 45: 507\u2013512.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR135","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/diacare.25.9.1511","volume":"25","author":"PP Simonen","year":"2002","unstructured":"Simonen PP, Gylling HK, Miettinen TA . Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 2002; 25: 1511\u20131515.","journal-title":"Diabetes Care"},{"key":"BF4001854_CR136","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ . Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256\u20131262.","journal-title":"Diabetes"},{"key":"BF4001854_CR137","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0531-5565(03)00153-0","volume":"38","author":"C Messier","year":"2003","unstructured":"Messier C . Diabetes, Alzheimer's disease and apolipoprotein genotype. Exp Gerontol 2003; 38: 941\u2013946.","journal-title":"Exp Gerontol"},{"key":"BF4001854_CR138","volume-title":"Brain Imaging and Brain Function","author":"DE Kuhl","year":"1985","unstructured":"Kuhl DE, Metter EJ, Riege WH . Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's Disease. In: Sokoloff L (ed). Brain Imaging and Brain Function. Raven Press: New York, 1985."},{"key":"BF4001854_CR139","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.36.7.879","volume":"36","author":"R Duara","year":"1986","unstructured":"Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L et al. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36: 879\u2013887.","journal-title":"Neurology"},{"key":"BF4001854_CR140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","volume":"17","author":"K Herholz","year":"2003","unstructured":"Herholz K . PET studies in dementia. Ann Nucl Med 2003; 17: 79\u201389.","journal-title":"Ann Nucl Med"},{"key":"BF4001854_CR141","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01688639208402827","volume":"14","author":"S Craft","year":"1992","unstructured":"Craft S, Zallen G, Baker LD . Glucose and memory in mild senile dementia of the Alzheimer type. J Clin Exp Neuropsychol 1992; 14: 253\u2013267.","journal-title":"J Clin Exp Neuropsychol"},{"key":"BF4001854_CR142","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.0954-6820.1983.tb03756.x","volume":"213","author":"G Bucht","year":"1983","unstructured":"Bucht G, Adolfsson R, Lithner F, Winblad B . Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983; 213: 387\u2013392.","journal-title":"Acta Med Scand"},{"key":"BF4001854_CR143","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0006-3223(91)90158-I","volume":"30","author":"Y Fujisawa","year":"1991","unstructured":"Fujisawa Y, Sasaki K, Akiyama K . Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiat 1991; 30: 1219\u20131228.","journal-title":"Biol Psychiat"},{"key":"BF4001854_CR144","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1600-0404.1993.tb05511.x","volume":"87","author":"L Kilander","year":"1993","unstructured":"Kilander L, Boberg M, Lithell H . Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta Neurol Scand 1993; 87: 294\u2013298.","journal-title":"Acta Neurol Scand"},{"key":"BF4001854_CR145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-3223(91)90313-B","volume":"30","author":"CH Winograd","year":"1991","unstructured":"Winograd CH, Jacobson DH, Minkoff JR, Peabody CA, Taylor BS, Widrow L et al. Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type. Biol Psychiat 1991; 30: 507\u2013511.","journal-title":"Biol Psychiat"},{"key":"BF4001854_CR146","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.410210507","volume":"21","author":"NR Sims","year":"1987","unstructured":"Sims NR, Finegan JM, Blass JP . Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann Neurol 1987; 21: 451\u2013457.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR147","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0531-5565(00)00156-X","volume":"35","author":"S Hoyer","year":"2000","unstructured":"Hoyer S . Brain glucose and energy metabolism abnormalities in sporadic Alzheimer's disease. Causes and consequences: an update. Exp Gerontol 2000; 35: 1363\u20131372.","journal-title":"Exp Gerontol"},{"key":"BF4001854_CR148","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/0735-7044.107.6.926","volume":"207","author":"S Craft","year":"1993","unstructured":"Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, Fleischman S et al. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 1993; 207: 926\u2013940.","journal-title":"Behav Neurosci"},{"key":"BF4001854_CR149","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-4580(93)90034-9","volume":"14","author":"CA Manning","year":"1993","unstructured":"Manning CA, Ragozzino ME, Gold PE . Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 1993; 14: 523\u2013528.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR150","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","volume":"102","author":"EM Reiman","year":"2005","unstructured":"Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 2005; 102: 8299\u20138302.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR151","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4522(99)00458-3","volume":"95","author":"AA Boyt","year":"2000","unstructured":"Boyt AA, Taddei TK, Hallmeyer J, Helmerhorst E, Gandy SE, Craft S et al. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neuroscience 2000; 95: 727\u2013734.","journal-title":"Neuroscience"},{"key":"BF4001854_CR152","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.mehy.2005.01.016","volume":"64","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Nakamura K, Inoue H, Kikuchi S, Takeuchi M . Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease. Med Hypotheses 2005; 64: 1205\u20131207.","journal-title":"Med Hypotheses"},{"key":"BF4001854_CR153","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","volume":"177","author":"WQ Zhao","year":"2001","unstructured":"Zhao WQ, Alkon DL . Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001; 177: 125\u2013134.","journal-title":"Mol Cell Endocrinol"},{"key":"BF4001854_CR154","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1074\/jbc.M111571200","volume":"277","author":"D Edbauer","year":"2002","unstructured":"Edbauer D, Willem M, Lammich S, Steiner H, Haass C . Insulin-degrading enzyme rapidly removes the \u03b2-amyloid precursor protein intracellular domain (AICD). J Biol Chem 2002; 277: 13389\u201313393.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR155","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100: 4162\u20134167.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR156","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archneur.62.10.noc50112","volume":"62","author":"MA Fishel","year":"2005","unstructured":"Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ et al. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol 2005; 62: 1539\u20131544.","journal-title":"Arch Neurol"},{"key":"BF4001854_CR157","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","volume":"63","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Tang MX, Shea S, Mayeux R . Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187\u20131192.","journal-title":"Neurology"},{"key":"BF4001854_CR158","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 2004; 18: 902\u2013904.","journal-title":"FASEB J"},{"key":"BF4001854_CR159","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R . Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 2002; 22: RC221.","journal-title":"J Neurosci"},{"key":"BF4001854_CR160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2002-4504","volume":"4","author":"L Xie","year":"2002","unstructured":"Xie L, Martins RN, Racchi M, Craft S, Helmerhorst E . Beta amyloid antagonizes insulin promoted secretion of the amyloid precursor protein. J Alzheimer's Dis 2002; 4: 369\u2013374.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR161","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1096\/fasebj.14.7.1015","volume":"14","author":"DC Solano","year":"2000","unstructured":"Solano DC, Sironi M, Bonfini C, Solerte SB, Govoni S, Racchi M . Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J 2000; 14: 1015\u20131022.","journal-title":"FASEB J"},{"key":"BF4001854_CR162","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","volume":"21","author":"L Gasparini","year":"2001","unstructured":"Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P et al. Stimulation of \u03b2-amyloid precursor protein trafficking by insulin reduces intraneuronal \u03b2-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21: 2561\u20132570.","journal-title":"J Neurosci"},{"key":"BF4001854_CR163","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.mp.4001344","volume":"8","author":"N Helbecque","year":"2003","unstructured":"Helbecque N, Abderrahamani A, Meylan L, Riederer B, Mooser V, Miklossy J et al. Islet-brain1\/C-Jun N-terminal kinase interacting protein-1 (IB1\/JIP-1) promoter variant is associated with Alzheimer's disease. Mol Psychiatry 2003; 8: 413\u2013422.","journal-title":"Mol Psychiatry"},{"key":"BF4001854_CR164","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/73523","volume":"24","author":"G Waeber","year":"2000","unstructured":"Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, Widmann C et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 2000; 24: 291\u2013295.","journal-title":"Nat Genet"},{"key":"BF4001854_CR165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","volume":"7","author":"SM De la Monte","year":"2005","unstructured":"De la Monte SM, Wands JR . Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimer's Dis 2005; 7: 45\u201361.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2004.02.042","volume":"490","author":"CA Bondy","year":"2004","unstructured":"Bondy CA, Cheng CM . Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004; 490: 25\u201331.","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 2","key":"BF4001854_CR167","first-page":"22","volume":"55","author":"J Dupont","year":"2001","unstructured":"Dupont J, LeRoith D . Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res 2001; 55 (Suppl 2): 22\u201326.","journal-title":"Horm Res"},{"key":"BF4001854_CR168","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0306-4522(97)00154-1","volume":"80","author":"S Dore","year":"1997","unstructured":"Dore S, Kar S, Rowe W, Quirion R . Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience 1997; 80: 1033\u20131040.","journal-title":"Neuroscience"},{"key":"BF4001854_CR169","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease \u2013 is this type 3 diabetes? J Alzheimer's Dis 2005; 7: 63\u201380.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR170","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.94.9.4772","volume":"94","author":"S Dore","year":"1997","unstructured":"Dore S, Kar S, Quirion R . Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci USA 1997; 94: 4772\u20134777.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR171","first-page":"261","volume":"60","author":"WH Zheng","year":"2000","unstructured":"Zheng WH, Kar S, Dore S, Quirion R . Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm Supp 2000; 60: 261\u2013272.","journal-title":"J Neural Transm Supp"},{"key":"BF4001854_CR172","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1074\/jbc.M111704200","volume":"277","author":"W Wei","year":"2002","unstructured":"Wei W, Wang X, Kusiak JW . Signaling events in amyloid \u03b2-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 2002; 277: 17649\u201317656.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR173","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0169-328X(97)00259-3","volume":"52","author":"WC Wallace","year":"1997","unstructured":"Wallace WC, Akar CA, Lyons WE, Kole HK, Egan JM, Wolozin B . Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res Mol Brain Res 1997; 52: 213\u2013227.","journal-title":"Brain Res Mol Brain Res"},{"key":"BF4001854_CR174","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","volume":"257","author":"SC Rall","year":"1982","unstructured":"Rall SC, Weisgraber KH, Mahley RW . Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982; 257: 4171\u20134178.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622\u2013630.","journal-title":"Science"},{"key":"BF4001854_CR176","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00001756-199507310-00012","volume":"6","author":"RN Martins","year":"1995","unstructured":"Martins RN, Clarnette R, Fisher C, Broe GA, Brooks WS, Montgomery P et al. Apo E genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport 1995; 6: 1513\u20131516.","journal-title":"NeuroReport"},{"key":"BF4001854_CR177","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","volume":"23","author":"VI Zannis","year":"1982","unstructured":"Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982; 23: 911\u2013914.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR178","first-page":"49","volume":"7","author":"MI Kamboh","year":"1989","unstructured":"Kamboh MI, Sepehrnia B, Ferrell RE . Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. Dis Markers 1989; 7: 49\u201355.","journal-title":"Dis Markers"},{"key":"BF4001854_CR179","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/geno.1998.5454","volume":"52","author":"J Gelernter","year":"1998","unstructured":"Gelernter J, Kranzler H, Lacobelle J . Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). Genomics 1998; 52: 289\u2013297.","journal-title":"Genomics"},{"key":"BF4001854_CR180","first-page":"598","volume":"121","author":"K Tsukamoto","year":"1993","unstructured":"Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993; 121: 598\u2013602.","journal-title":"J Lab Clin Med"},{"key":"BF4001854_CR181","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/aje\/155.6.487","volume":"155","author":"JE Eichner","year":"2002","unstructured":"Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC . Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002; 155: 487\u2013495.","journal-title":"Am J Epidemiol"},{"key":"BF4001854_CR182","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","volume":"76","author":"PS Roheim","year":"1979","unstructured":"Roheim PS, Carey M, Forte T, Vega GL . Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA 1979; 76: 4646\u20134649.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR183","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","volume":"262","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH . Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem 1987; 262: 14352\u201314360.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR184","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.92.21.9480","volume":"92","author":"DM Holtzman","year":"1995","unstructured":"Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 1995; 92: 9480\u20139484.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW . Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987; 917: 148\u2013161.","journal-title":"Biochim Biophys Acta"},{"key":"BF4001854_CR186","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s001090050356","volume":"77","author":"TE Willnow","year":"1999","unstructured":"Willnow TE . The low density lipoprotein receptor gene family: multiple roles in lipid metabolism. J Mol Med 1999; 77: 306\u2013315.","journal-title":"J Mol Med"},{"key":"BF4001854_CR187","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.semcdb.2005.01.005","volume":"16","author":"JE Vance","year":"2005","unstructured":"Vance JE, Hayashi H, Karten B . Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 2005; 16: 193\u2013212.","journal-title":"Semin Cell Dev Biol"},{"key":"BF4001854_CR188","first-page":"337","volume":"72","author":"P Oner","year":"1991","unstructured":"Oner P, Bekpinar S, Oz B . Alterations in some lipid components and Ca2+ ATPase activity in brains of rats fed an atherogenic diet. Res Commun Chem Pathol Pharmacol 1991; 72: 337\u2013345.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF4001854_CR189","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.138.4.877","volume":"138","author":"B Dehouck","year":"1997","unstructured":"Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R . A new function for the LDL receptor: transcytosis of LDL across the blood\u2013brain barrier. J Cell Biol 1997; 138: 877\u2013889.","journal-title":"J Cell Biol"},{"key":"BF4001854_CR190","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS et al. Apolipoprotein E: high-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 1977\u20131981.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR191","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1073\/pnas.92.19.8552","volume":"92","author":"GD Schellenberg","year":"1995","unstructured":"Schellenberg GD . Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc Natl Acad Sci USA 1995; 92: 8552\u20138559.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR192","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ana.410380319","volume":"38","author":"BO Osuntokun","year":"1995","unstructured":"Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A et al. Lack of association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 1995; 38: 463\u2013465.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR193","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.285.6.739","volume":"285","author":"HC Hendrie","year":"2001","unstructured":"Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001; 285: 739\u2013747.","journal-title":"JAMA"},{"key":"BF4001854_CR194","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JAD-1999-14-502","volume":"1","author":"MA Smith","year":"1999","unstructured":"Smith MA, Petot GJ, Perry G . Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease. J Alzheimer Dis 1999; 1: 203\u2013206.","journal-title":"J Alzheimer Dis"},{"key":"BF4001854_CR195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/meta.2003.50066","volume":"52","author":"GJ Petot","year":"2003","unstructured":"Petot GJ, Traore F, Debanne SM, Lerner AJ, Smyth KA, Friedland RP . Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. Metabolism 2003; 52: 279\u2013281.","journal-title":"Metabolism"},{"key":"BF4001854_CR196","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2004.01.015","volume":"16","author":"M Mulder","year":"2004","unstructured":"Mulder M, Jansen JP, Janssen BJ, van de Berg WD, van der Boom H, Havekes LM et al. Low density lipoprotein receptor knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus. Neurobiol Dis 2004; 16: 212\u2013219.","journal-title":"Neurobiol Dis"},{"key":"BF4001854_CR197","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02815210","volume":"1","author":"I Gordon","year":"1996","unstructured":"Gordon I, Genis I, Grauer E, Sehayek E, Michaelson DM . Biochemical and cognitive studies of apolipoprotein E deficient mice. Mol Chem Neuropathol 1996; 1: 97\u2013103.","journal-title":"Mol Chem Neuropathol"},{"key":"BF4001854_CR198","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jns.2004.11.035","volume":"229\u2013230","author":"O Levi","year":"2005","unstructured":"Levi O, Jongen-Relo AL, Feldon J, Michaelson DM . Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4. J Neurol Sci 2005; 229\u2013230: 241\u2013248.","journal-title":"J Neurol Sci"},{"key":"BF4001854_CR199","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","volume":"264","author":"BP Nathan","year":"1994","unstructured":"Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE . Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850\u2013852.","journal-title":"Science"},{"key":"BF4001854_CR200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3940(98)00180-3","volume":"245","author":"BL Scott","year":"1998","unstructured":"Scott BL, Welch K, deSerrano V, Moss NC, Roses AD, Strittmatter WJ . Human apolipoprotein E accelerates microtubule polymerization in vitro. Neurosci Lett 1998; 245: 105\u2013108.","journal-title":"Neurosci Lett"},{"key":"BF4001854_CR201","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.1074\/jbc.270.34.19791","volume":"270","author":"BP Nathan","year":"1995","unstructured":"Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW et al. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 1995; 270: 19791\u201319799.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR202","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1523\/JNEUROSCI.18-09-03261.1998","volume":"18","author":"Y Sun","year":"1998","unstructured":"Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ et al. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J Neurosci 1998; 18: 3261\u20133272.","journal-title":"J Neurosci"},{"key":"BF4001854_CR203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","volume":"11","author":"J Poirier","year":"1991","unstructured":"Poirier J, Hess M, May PC, Finch CE . Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 1991; 11: 97\u2013106.","journal-title":"Brain Res Mol Brain Res"},{"key":"BF4001854_CR204","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0197-4580(97)00055-9","volume":"18","author":"JC Morris","year":"1997","unstructured":"Morris JC . The challenge of characterizing normal brain aging in relation to Alzheimer's disease. Neurobiol Aging 1997; 18: 388\u2013389.","journal-title":"Neurobiol Aging"},{"key":"BF4001854_CR205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","volume":"55","author":"J Poirier","year":"1993","unstructured":"Poirier J, Baccichet A, Dea D, Gauthier S . Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 1993; 55: 81\u201390.","journal-title":"Neuroscience"},{"key":"BF4001854_CR206","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1471-4159.2004.02581.x","volume":"90","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC, Deng A, Lleo A, Berezovska O, Von Arnim CA, Martin-Rehrmann M et al. Apolipoprotein E modulates \u03b3-secretase cleavage of the amyloid precursor protein. J Neurochem 2004; 90: 1132\u20131143.","journal-title":"J Neurochem"},{"key":"BF4001854_CR207","first-page":"13892","volume":"273","author":"S Hass","year":"2001","unstructured":"Hass S, Fresser F, Kochl S, Beyreuther K, Utermann G, Baier G . Physical interaction of apo E with amyloid precursor protein independent of the amyloid abeta region in vitro. J Biol Chem 2001; 273: 13892\u201313897.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR208","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s004380100473","volume":"265","author":"S Hass","year":"2001","unstructured":"Hass S, Weidemann A, Utermann G, Baier G . Intracellular apolipoprotein E affects amyloid precursor protein processing and amyloid abeta production in COS-1 cells. Mol Genet Genomics 2001; 265: 791\u2013800.","journal-title":"Mol Genet Genomics"},{"key":"BF4001854_CR209","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K . Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991; 541: 163\u2013166.","journal-title":"Brain Res"},{"key":"BF4001854_CR210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B . Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992; 135: 235\u2013238.","journal-title":"Neurosci Lett"},{"key":"BF4001854_CR211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","volume":"15","author":"J Naslund","year":"1995","unstructured":"Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N et al. Characterization of stable complexes involving apo E and amyloid beta peptide in Alzheimer's disease brain. Neuron 1995; 15: 219\u2013228.","journal-title":"Neuron"},{"key":"BF4001854_CR212","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649\u20139653.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.410390320","volume":"39","author":"M Gearing","year":"1996","unstructured":"Gearing M, Mori H, Mirra SS . Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1996; 39: 395\u2013399.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR214","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj3060599","volume":"306","author":"EM Castano","year":"1995","unstructured":"Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C et al. Fibrillogenesis in Alzheimer's disease of amyloid \u03b2 peptides and apolipoprotein E. Biochem J 1995; 306: 599\u2013604.","journal-title":"Biochem J"},{"key":"BF4001854_CR215","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M . Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform specific effects and implications for late onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098\u20138102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR216","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A et al. Apolipoprotein E associates with \u03b2 amyloid peptide of Alzheimer's disease to form novel fibrils. J Clin Invest 1994; 94: 860\u2013869.","journal-title":"J Clin Invest"},{"key":"BF4001854_CR217","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE . Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 1994; 269: 23403\u201323406.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR218","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","volume":"270","author":"MJ LaDu","year":"1995","unstructured":"LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT . Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem 1995; 270: 9039\u20139042.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR219","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.1997.68020721.x","volume":"68","author":"DS Yang","year":"1997","unstructured":"Yang DS, Smith JD, Zhou Z, Gandy SE, Martins RN . Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J Neurochem 1997; 68: 721\u2013725.","journal-title":"J Neurochem"},{"key":"BF4001854_CR220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03401614","volume":"2","author":"Z Zhou","year":"1996","unstructured":"Zhou Z, Smith JD, Greengard P, Gandy SE . Alzheimer amyloid-\u03b2 peptide forms denaturant-resistant complex with Type \u00e53 but not \u00e54 isoform of native apolipoprotein E. Mol Med 1996; 2: 175\u2013180.","journal-title":"Mol Med"},{"key":"BF4001854_CR221","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1523\/JNEUROSCI.18-01-00195.1998","volume":"18","author":"J Jordan","year":"1998","unstructured":"Jordan J, Galindo MF, Miller RJ, Reardon CA, Getz GS, LaDu MJ . Isoform-specific effect of apolipoprotein E on cell survival and \u03b2-amyloid induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 1998; 18: 195\u2013204.","journal-title":"J Neurosci"},{"key":"BF4001854_CR222","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0306-4522(98)00561-2","volume":"90","author":"DS Yang","year":"1999","unstructured":"Yang DS, Small DH, Seydel U, Smith JD, Hallmayer J, Gandy SE et al. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience 1999; 90: 1217\u20131226.","journal-title":"Neuroscience"},{"key":"BF4001854_CR223","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/JMN:23:3:235","volume":"23","author":"AM Manelli","year":"2004","unstructured":"Manelli AM, Stine WB, Van Eldick LJ, LaDu MJ . ApoE and Abeta1\u201342 interactions: effects of isoform and conformation on structure and function. J Mol Neurosci 2004; 23: 235\u2013246.","journal-title":"J Mol Neurosci"},{"key":"BF4001854_CR224","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-2005-7406","volume":"7","author":"E Hone","year":"2005","unstructured":"Hone E, Martins IJ, Jeoung M, Ji TH, Gandy S, Martins RN . Alzheimer's disease A\u03b2 peptide modulates apoE isoform specific effects on receptor binding. J Alzheimers Dis 2005; 7: 303\u2013314.","journal-title":"J Alzheimers Dis"},{"key":"BF4001854_CR225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2003-5101","volume":"5","author":"E Hone","year":"2003","unstructured":"Hone E, Martins IJ, Fonte J, Martins RN . Apolipoprotein E influences amyloid-beta clearance from the murine periphery. J Alzheimer's Dis 2003; 5: 1\u20138.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","volume":"40","author":"K Winkler","year":"1999","unstructured":"Winkler K, Scharnagl H, Tisljar U, Hoschutzky H, Friedrich I, Hoffmann MM . Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J Lipid Res 1999; 40: 447\u2013455.","journal-title":"J Lipid Res"},{"key":"BF4001854_CR227","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","volume":"89","author":"BV Zlokovic","year":"2004","unstructured":"Zlokovic BV . Clearing amyloid through the blood brain barrier. J Neurochem 2004; 89: 807\u2013814.","journal-title":"J Neurochem"},{"key":"BF4001854_CR228","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB et al. P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model. J Clin Invest 2005; 115: 3285\u20133290.","journal-title":"J Clin Invest"},{"key":"BF4001854_CR229","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","volume":"11","author":"Z Wu","year":"2005","unstructured":"Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R et al. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 2005; 11: 959\u2013965.","journal-title":"Nat Med"},{"key":"BF4001854_CR230","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 2892\u20132897.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001854_CR231","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.10618","volume":"54","author":"X Han","year":"2003","unstructured":"Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM . Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann Neurol 2003; 54: 115\u2013119.","journal-title":"Ann Neurol"},{"key":"BF4001854_CR232","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1074\/jbc.M212340200","volume":"278","author":"X Han","year":"2003","unstructured":"Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM . Novel role for apolipoprotein E in the central nervous system. J Biol Chem 2003; 278: 8043\u20138051.","journal-title":"J Biol Chem"},{"key":"BF4001854_CR233","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(00)02790-6","volume":"886","author":"MP Mattson","year":"2000","unstructured":"Mattson MP . Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res 2000; 886: 47\u201353.","journal-title":"Brain Res"},{"key":"BF4001854_CR234","first-page":"174","volume":"44","author":"RD Brinton","year":"1999","unstructured":"Brinton RD . A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health. Int J Fertil Womens Med 1999; 44: 174\u2013185.","journal-title":"Int J Fertil Womens Med"},{"key":"BF4001854_CR235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JAD-2002-4308","volume":"4","author":"WB Grant","year":"2002","unstructured":"Grant WB, Campbell A, Itzhaki RF, Savory J . The significance of environmental factors in the etiology of Alzheimer's disease. J Alzheimer's Dis 2002; 4: 179\u2013189.","journal-title":"J Alzheimer's Dis"},{"key":"BF4001854_CR236","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00702-002-0766-8","volume":"110","author":"V Solfrizzi","year":"2003","unstructured":"Solfrizzi V, Panza F, Capurso A . The role of diet in cognitive decline. J Neural Transm 2003; 110: 95\u2013110.","journal-title":"J Neural Transm"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001854","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:27:47Z","timestamp":1648783667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,20]]},"references-count":236,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8,1]]}},"alternative-id":["BF4001854"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001854","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,20]]},"assertion":[{"value":"28 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}